The mu-opioid receptor is a molecular marker for poor prognosis in hepatocellular carcinoma and represents a potential therapeutic target - Chen, D.T.; Pan, J.H.; Chen, Y.H.; Xing, W.; Yan, Y.; Yuan, Y.F.; Zeng, W.A. (British journal of anaesthesia : BJA, 2019)
Keywords: cancer; cancer therapy; carcinoma; hepatocellular; metastasis; mu opioid receptors; opioids; prognosis; cancer therapy; carcinoma; metastasis; cancer; prognosis; mu opioid receptors; hepatocellular; opioids